2,308
Views
8
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

, , , , , ORCID Icon, , , , & show all
Pages 751-759 | Received 05 Feb 2019, Accepted 21 Mar 2019, Published online: 25 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Darko Mitrovic, Marlies Plomp, Richard Folkeringa, Nic Veeger, Talitha Feenstra & Eric van Roon. (2021) Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist oral anticoagulant. Current Medical Research and Opinion 37:9, pages 1461-1466.
Read now
Dejan Milentijevic, Jennifer H. Lin, Yen-Wen Chen, Emily Kogan, Shubham Shrivastava, Erik Sjoeland & Mark Alberts. (2021) Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin. Journal of Medical Economics 24:1, pages 212-217.
Read now

Articles from other publishers (6)

J. Robert Powell, Farah Al Qaraghuli, Jill Fiedler‐Kelly, Daniel Gonzalez & Daniel Weiner. (2023) Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients. Clinical Pharmacology & Therapeutics 114:2, pages 362-370.
Crossref
Adam E. Berman, Mina Kabiri, Tom WeiThibaut Galvain, Qun Sha & Karl-Heinz Kuck. (2023) Economic and Health Value of Delaying Atrial Fibrillation Progression Using Radiofrequency Catheter Ablation. Circulation: Arrhythmia and Electrophysiology 16:4.
Crossref
Katherine A. Vilain, Peter M. DiBattiste, David J. Schneider & David J. Cohen. (2022) Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention. Coronary Artery Disease 34:1, pages 24-33.
Crossref
Jose Osorio, Moussa Mansour, Daniel Melby, Ryan J. Imhoff, Tina D. Hunter, Sonia Maccioni, Tom Wei & Andrea Natale. (2022) Economic Evaluation of Contact Force Catheter Ablation for Persistent Atrial Fibrillation in the United States. Heart Rhythm O2 3:6, pages 647-655.
Crossref
Muideen T. Olaiya, Nita Sodhi-Berry, Lachlan L. Dalli, Kiran Bam, Amanda G. Thrift, Judith M. Katzenellenbogen, Lee Nedkoff, Joosup Kim & Monique F. Kilkenny. (2022) The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature. Current Neurology and Neuroscience Reports 22:3, pages 151-160.
Crossref
Steven B. Deitelzweig, Belinda Lovelace, Mary Christoph, Melissa Lingohr-Smith, Jay Lin & Gregory J. Fermann. (2020) Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA. Advances in Therapy 37:9, pages 3942-3953.
Crossref